Valuation dashboard for Waters Corporation (WAT) with P/E 106.04, P/B 8.83, EV/EBITDA 23.23 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems.
Analysis Summary
Waters Corporation reported revenue of $3.17B in the most recent fiscal year, growing at a 5-year CAGR of 6.0%. Net income reached $642.6M, with a 4.3% 5-year CAGR.
Trailing-twelve-month margins: gross margin 57.8%, operating margin 28.2%, net margin 20.3%.
At the current price of $440.12, WAT trades at a P/E of 106.04 and an ROE of 25.09%. Market capitalisation stands at $43.2B, placing it among large-cap names.
Balance sheet quality for WAT: current ratio of 1.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 106.04 |
| Price / Book | 8.83 |
| EV / EBITDA | 23.23 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $204.46 |
| vs Current Price | -53.5% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| WAT | Waters Corporation | $41.7B | 106.04 | 8.83 | 25.1% |
| DXCM | DexCom, Inc. | $32.2B | 33.74 | 12.49 | 36.2% |
| INCY | Incyte Corporation | $23.4B | 14.69 | 3.64 | 29.7% |
| ILMN | Illumina, Inc. | $41.3B | 50.94 | 14.53 | 31.2% |
| MEDP | Medpace Holdings, Inc. | $16.7B | 35.33 | 40.09 | 110.1% |
| MTD | Mettler-Toledo International Inc. | $30.0B | 33.45 | 2,332.10 | -36.8% |
| STE | STERIS plc | $20.3B | 25.49 | 2.82 | 11.3% |
| LH | Labcorp Holdings Inc. | $25.3B | 25.52 | 2.93 | 11.6% |
Price
| Price | $440.12 |
| Market Cap | $43.2B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | 25.09% |
| Return on Invested Capital | 17.57% |
| Return on Assets | 12.66% |
| Gross Margin | 57.77% |
| Operating Margin | 28.22% |
| Net Margin | 20.30% |
Related companies: DGX · DXCM · ILMN · INCY · LH · MEDP · MTD
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of WAT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks